Clinical trial
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive…
NCT00105989 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00105989 |
|---|---|
| Title | Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder |
| Official title | Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Duloxetine, placebo |
| Enrollment | 514 |
| Start date | Mar 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 21, 2005 |
| Last update posted | Jul 28, 2009 |
| Countries | France, Germany, Italy, Russia, Sweden, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: